Journals / Türk Anestezi ve Reanimasyon Dergisi / 2014 / Cilt: 42 - Sayı: 1

Posterior reversible encephalopathy syndrome in an eclamptic patient after cardiac arrest; case report and literature review

Kardiyak arest geçiren eklamptik hastada gelişen posterior reversible ensefalopati sendromu; olgu sunumu ve literatürün gözden geçirilmesi

Pages
50–53
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report, a 19-year old, 32 week pregnant eclamptic woman, who had been diagnosed with PRES, is presented with a discussion of the rele- vant literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Posterior reversible encephalopathy (PRES) is a disorder char- acterized by hypertension, headache, seizures and visual impair- ment.
📊
Key Findings & Data:Causes of PRES include; severe hypertension, pre-eclamp- sia or eclampsia, sepsis, history of renal and autoimmune diseases and use of immunosuppressive or cytotoxic agents.
💡
Conclusion & Impact:In this report, a 19-year old, 32 week pregnant eclamptic woman, who had been diagnosed with PRES, is presented with a discussion of the rele- vant literature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Posterior reversible encephalopathy (PRES) is a disorder char- acterized by hypertension, headache, seizures and visual impair- ment. Causes of PRES include; severe hypertension, pre-eclamp- sia or eclampsia, sepsis, history of renal and autoimmune diseases and use of immunosuppressive or cytotoxic agents. Diagnosis of the syndrome can be difficult. For this reason clinical and radio- logical findings should be evaluated together. In this report, a 19-year old, 32 week pregnant eclamptic woman, who had been diagnosed with PRES, is presented with a discussion of the rele- vant literature.

Özet

Posterior reversible ensefalopati sendromu (PRES), hipertansiyon, başağrısı, nöbetler ve görsel bozuklukla karakterize bir hastalık- tır. PRESin nedenleri; ağır hipertansiyon, preeklampsi, eklampsi, sepsis, renal ve otoimmün hastalıklar, immünosupresif ve sito- toksik ajanların kullanımıdır. Sendromun tanısı zor olabilir. Bu nedenle klinik ve radyolojik bulgular birlikte değerlendirilmelidir. Bu bildiride, PRES tanısı alan, 19 yaşında 32 haftalık gebe ek- lamptik hasta literatür eşliğinde sunulmuştur.

🔖

Cite This Article

HONCA, M., POLAT, A., HOROSANLI, E. (2014). Posterior reversible encephalopathy syndrome in an eclamptic patient after cardiac arrest; case report and literature review. Türk Anestezi ve Reanimasyon Dergisi, Cilt: 42 - Sayı: 1, 50–53. https://ajindex.com/articles/395102

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopaty syndrome. N Engl J Med 1996; 334: 494-500. [CrossRef ] Garg RK. Posterior leukoencephalopaty syndrome.Postgrad Med J 2001; 77: 24-8. [CrossRef ] Kastrup O, Maschke M, Wanke I, Diener HC. Posterior re- versible encephalopaty due to hypercalsemia. J Neurol 2002; 249: 1563-6. [CrossRef ] Turker M, Zeyneloglu P, Pirat A, Araz C, Donmez F, Can U, et al. Posterior reversible encephalopaty syndrome (PRES)- Acase report. Journal of Turkish Society of Intensive Care 2011; 9: 103-6.
  2. Pratap JN, Down JF. Posterior reversible encephalopaty syn- drome: A report of a case with atypical features. Anaesthesia 2008; 63: 1245-8. [CrossRef ] Lee V, Wijdicks EFM, Manno E, Rabinstein A. Clinical spec- trum of reversible posterior leukoencephalopaty syndrome. Arch Neurol 2008; 65: 205-10. [CrossRef ] Pande A, Ando K, Ishikura R, Nagami Y, Takada Y, Wada A, et al. Clinicoradiological factors influencing the reversibility of posterior reversible encephalopaty syndrome: a multicenter study. Radiat Med 2006; 24: 659-68. [CrossRef ] Li R, Mitchell P, Dowling R, Yan B. Is hypertension predictive of clinical recurrence in posterior reversible encephalopaty syn- drome? J Clin Neurosci 2013; 20: 248-52. [CrossRef ] Schwartz RB, Mulkern RV, Gudbjartsson H, Jolesz F. Diffu- sion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis. AJNR Am J Neuroradiol 1998; 19: 859-62.
  3. Casey SO, Sampaio RC, Michel E, Truwit CL. Posterior revers- ible encephalopathy syndrome: utility of fluid-attenuated inver- sion recovery MR imaging in the detection of cortical and sub- cortical lesions. AJNR Am J Neuroradiol 2000; 21: 1199-206.
  4. Fugate JE, Claassen DO,Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA. Posterior reversible encephalopathy syndrome: associated clinical and radiological findings. Mayo Clin Proc 2010; 85: 427-32. [CrossRef ] Euser AG, Cipolla MJ. Magnesium sulfate for the treatment of eclampsia: a brief review. Stroke 2009; 40: 1169-75. [CrossRef] Martin JN Jr, Thigpen BD, Moore RC, Rose CH, Cushman J, May WL. Stroke and severe preeclampsia/eclampsia: a pradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005; 105: 246-54. [CrossRef ] Bebawy JF.Perioperative steroids for peritumoral intracrani- al edema: a review of mechanisms, efficacy, and side effects. J Neurosurg Anesthesiol 2012; 24: 173-7. [CrossRef ] Brewer J, Owens MY, Wallace K, Reeves AA, Morris